Du et al. showed that icariside II, an active component of Herba Epimedii, could potentiate TRAIL-driven cell death in melanoma A375 cells, presenting a low response to the pro-apoptotic action of the cytokine, through the ROS-mediated downregulation of STAT3/c-FLIP signaling. This evidence concerns the gene CFLAR and melanoma.